Drugs / Theravac
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01331915 | Sep 2010 → Oct 2013 | melanoma | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Theravac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01331915 ↗ |
| Modality | Vaccine | “Therapeutic Vaccination” NCT01331915 ↗ |